Working… Menu

A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02804178
Recruitment Status : Completed
First Posted : June 17, 2016
Last Update Posted : March 21, 2018
Information provided by (Responsible Party):
Millendo Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 17, 2017
Actual Study Completion Date : August 17, 2017